From COVID-19 to encephalitic alphaviruses, School of Pharmacy Associate Professor Jennifer Golden and collaborators are developing new antiviral treatments.
NIH grant
Advanced Polymeric Nanotechnology for Delivering Combination Cancer Therapies
Professor Glen Kwon receives a new grant from the National Institutes of Health for research targeting triple-negative breast cancer.
Gel Loaded with Cancer-Fighting Cells Keeps Tumors in Check After Surgery in Mice
A new, biodegradable gel, created by Assistant Professor Quanyin Hu, filled with a cocktail of immune-boosting cytokines and cancer-fighting cells staved off the growth of lingering cancer cells in mice after tumors were surgically removed.
Weiping Tang Receives NIH Grant for Coronavirus Research
Here are 3 things to know about the Tang Lab’s work toward antiviral therapeutics targeting a broad range of coronaviruses.
R35 Grant Accelerates New Molecule Discovery
With funding from the National Institutes of Health, Assistant Professor Jason Kwan explores new methods to discover drug candidates.
New Research Could Unlock Old Antibiotics to Treat MRSA
With a new R01 grant from the National Institutes of Health, Associate Professor Warren Rose is testing a MRSA subset that might not be as resistant to beta-lactams as previously thought.
$30 Million NIH Award will Help Tackle the Toughest Pathogens
Professor Tim Bugni and his colleagues receive $30 million grant from the NIH to take aim at the growing threat of multi-drug-resistant pathogens for which few — or no — treatment options exist.
UW–Madison School of Pharmacy’s Jennifer Golden Designs Promising New Compounds To Fight Deadly Mosquito-Transmitted Viruses
The School of Pharmacy makes a breakthrough in creating new small molecules that penetrate into the brain where the equine encephalitis viruses reside and interfere with viral replication to stop EEV. The research is funded by a new, five-year $21 million award from the National Institutes of Health (NIH).